Areas of Focus
- Function and mechanism of non-coding RNA in the diagnosis and treatment of gastrointestinal tumors
- Research on drug resistance mechanisms in pancreatic cancer
Work Experience
- 2021/01–Present - University of Science and Technology of China First Affiliated Hospital, Department of Gastroenterology - Associate Chief Physician
- 2016/01–2020/12 - University of Science and Technology of China First Affiliated Hospital, Department of Gastroenterology - Attending Physician
- 2014/07–2015/12 - University of Science and Technology of China First Affiliated Hospital, Department of Gastroenterology - Resident Physician
- 2010/07–2011/08 - Yijishan Hospital of Wannan Medical College, Department of Oncology - Resident Physician
Academic Background & Achievements
- 2011/09–2014/06 Doctorate in Internal Medicine: Shanghai Jiao Tong University
- 2007/09–2010/06 Master's in Oncology: Southeast University
- 2002/09–2014/06 Bachelor's in Clinical Medicine: Bengbu Medical College
- Hosted National Natural Science Foundation project
- Published over 10 papers, 5 as first author in SCI journals
Publications
- circACTR2 attenuates gemcitabine chemoresistance in pancreatic cancer through PTEN mediated PI3K/AKT signaling pathway, Xu C (#) (*), Ye Q, Ye C, Liu S, 2023
- Entecavir in the treatment of hepatitis b cirrhosis and its effect on liver histology and serum complement levels, Xiao M, Xu C, etc., 2021
- Microarray analysis of circular RNA expression profile associated with gemcitabine resistance in pancreatic cancer cells, Xu C(#), Yu Y, Ding F, 2018
- 辅助金属夹在内镜下组织胶注射治疗2型食管胃静脉曲张的胃底静脉曲张应用观察, 许朝,陈思,王松,等, 2020